港股異動|多重利好加身 晶泰科技大升20%創上市新高
“18C第一股”晶泰科技(2228.HK)午後繼續走高,一度大升20%至8.04港元,股價創上市以來新高,市值約275億港元。晶泰科技上市2個多月以來整體震盪走強,現價與IPO價格5.28港元相比,已累升超52%。晶泰科技昨日晚間公佈上半年業績,期內營收約人民幣1.03億元,同比增長28.34%。公吿稱,公司今年上半年首次取得了藥物發現解決方案業務的臨牀階段里程碑付款,這是其商業化途徑中的重要里程碑事件。此外,公司業務還在利用人工智能及自動化賦能新材料研發方面取得了重要的商業進展。於2024年8月,晶泰科技與協鑫集團有限公司簽訂了為期5年的戰略研發合作協議,預期協鑫集團將向晶泰科技支付的研發服務費用超1.35億美元(約人民幣10億元)。此外據悉,晶泰科技獲納入恒生綜合指數和恒生滬深港通大灣區綜合指數,將於2024年9月9日(星期一)起生效。這代表了資本市場對公司的業務表現、價值及發展前景的認可,將有助於擴大股東基礎並增加股份的流通性,從而提高公司在資本市場的投資價值及品牌聲譽。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.